AVEVA has announced today the release of a new business paper: ‘The Digital Asset Approach – Defining a new era of collaboration in capital projects and asset operations’. This paper focuses on the importance of the Digital Asset for both engineering, procurement and construction companies (EPCs) and Owner Operators (OOs).

One of the consistent challenges in both major capital projects and asset operations is the availability to all stakeholders of trusted information for effective and timely decision-making. Through the collaborative creation, sharing and maintenance of a Digital Asset throughout the lifecycle of its physical equivalent, all parties can improve their collective business processes and increase ROI.

"The Digital Asset approach has been central to our product development for many years," said Mat Truche-Gordon, executive vice-president – business strategy and marketing, AVEVA.

"At AVEVA, we want to help EPCs and OOs to work together more effectively to deliver on-time, on-budget projects and ensure reliable plant operations. We have seen this approach help our customers to ‘Unlock the Power of their Digital Asset’ to support every stage of the asset lifecycle.

"Having access to trusted information enables EPCs and OOs in capital intensive industries to make the right decisions at the right time. For projects, our customers are eradicating costly rework due to avoidable errors and miscommunication, and as a result are delivering better schedule assurance and capital control. In operations, having fast, easy access to asset information ensures our customers are increasing safety, reliability and plant availability."

AVEVA’s Digital Asset approach is unique, as it extracts greater value for customers from AVEVA’s tightly-integrated authoring applications, and is also open and flexible, accommodating information from any source. This allows customers the complete freedom to continue to use any preferred applications for maximum benefit and minimum disruption.

For more information, please contact AVEVA.